NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	155.96B
Revenue (ttm)	297.73B
Net Income (ttm)	23.02B
Shares Out	17.70M
EPS (ttm)	1,300.00
PE Ratio	6.78
Forward PE	n/a
Dividend	200.00 (2.27%)
Ex-Dividend Date	Dec 27, 2024

Volume	57,148
Average Volume	66,472
Open	8,920.00
Previous Close	9,000.00
Day's Range	8,630.00 - 8,970.00
52-Week Range	6,650.00 - 11,770.00
Beta	0.22
RSI	57.82
Earnings Date	Mar 21, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 417
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2023, NOVAREX's revenue was 302.17 billion, an increase of 7.28% compared to the previous year's 281.68 billion. Earnings were 22.04 billion, an increase of 10.26%.